Sandborn W, Feagan BG, Gasink C, et al (2016) A phase 3 randomized, multicenter, double-blind, placebo-controlled study of ustekinumab maintenance therapy in moderate–severe Crohn’s disease patients: Results from IM-UNITI. Gastroenterology AGA abstract 768
Keyword(s):
Phase 3
◽